jan 1, 1998 - NCI-Sponsored Breast Cancer Prevention Trial

Description:

Results of the NCI-sponsored Breast Cancer Prevention Trial show that the antiestrogen drug tamoxifen can reduce the incidence of breast cancer among women who are at increased risk of the disease by about 50%. FDA approves tamoxifen to reduce the incidence of breast cancer in women at increased risk.

Added to timeline:

Date: